Deadline Passes For Pfizer To Submit Results Of Post-Vaccination Heart Inflammation Study To US Regulators
Deadline Passes For Pfizer To Submit Results Of Post-Vaccination Heart Inflammation Study To US Regulators
…
25,670€
1,82%
Echtzeit-Aktienkurs Pfizer Inc.
Bid:
Ask:
Nachrichten zur Pfizer Inc. Aktie
Supreme Court declines to hear Pfizer case on financial assistance to Medicare enrollees
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer: Hoffnung auf weltweit ersten RSV-Impfstoff - Aktienanalyse
Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse von der Raiffeisen Bank International AG:
Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI), rät in…
Pfizer director used exclusive channel to ask Twitter to censor Covid-19 vaccine skeptics
In yet another release of Twitter insider information by new owner Elon Musk, reporter Alex Berenson reported on Jan. 9…
Chinese health expert: local production of Paxlovid should be able to start soon
...BEIJING (Reuters) - Supplies of Pfizers Paxlovid in China......…
Hewlett Packard Enterprise adds former Pfizer CFO to its board
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
Pfizer (PFE) closed at $47.62 in the latest trading session, marking a -1.59% move from the prior day....…
HPE appoints former Pfizer CFO DAmelio to board
Hewlett Packard Enterprise Co. on Tuesday appointed Frank D'Amelio, former chief financial officer of Pfizer Inc. , to HPE's…
Thinking about trading options or stock in TD Synnex, Apple, Pfizer, Advanced Micro Devices, or Verizon?
NEW YORK, Jan. 10, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNX, AAPL, PFE, AMD, and VZ. Click…
Pfizer CEO Dismisses Reports of a Paxlovid Generic for China
Whats new: Pfizer Inc. CEO Albert Bourla shot down reports that the pharmaceutical giant is working with a company in…
Stocks Slip Lower, Powell Speech, Pfizer Oak Street, Microsoft - Five Things To Know
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer says in talks with China over pricing of Covid pill
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer in talks with China over pricing of Covid pill
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
FDA Deviated From Normal Process In Pfizer Vaccine Approval, Documents Show
FDA Deviated From Normal Process In Pfizer Vaccine Approval, Documents Show
…
UPDATE 1-Pfizer CEO says there will be no generic Paxlovid for China
...(Adds details from CEO Bourla)
Jan 9 (Reuters) - Pfizer Inc... on Monday.
Reuters reported on Friday that China was in talks…
Pfizer Says Partner in China Is Gearing up for Paxlovid Sales
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer not in talks on licensing generic COVID pill in China
...NEW YORK (Reuters) - Pfizer Inc Chief Executive Albert Bourla......…
This Censorious Pfizer Board Member Was A Major Influence On Lockdowns
This Censorious Pfizer Board Member Was A Major Influence On Lockdowns
…
Pfizer projects up to $84B non COVID revenue in 2030
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer working to send COVID pill Paxlovid to China - CNBC
...(Reuters) - Pfizer Inc is working with Chinese authorities... to a Reuters request for comment on…
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients.
read…
UPDATE 1-U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication
... (Reuters) - The U.S. Supreme Court on
Monday turned away Pfizer Incs......…
U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication
...WASHINGTON (Reuters) - The U.S. Supreme Court on Monday turned......…
This Stock Could Be a Surprise Growth Pick for 2023
Pfizer is about to enter a whole new era of growth....…
Pfizer Rejected by CN Medical Insurance Drug Catalogue due to High Price; CN in Talks About Producing Paxlovid Generic Drug
The negotiation on the 2022 National Medical Insurance Drug Catalogue has officially concluded yesterday (8th), China's National Healthcare Security Administration…
It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.
With rates rising, biotech has faded. Investors have favored the pharma stalwarts. Bank of America’s drug analyst Geoff Meacham runs…
Exclusive-China in talks with Pfizer for generic COVID drug - sources
...By Julie Zhu and Kevin Huang
HONG KONG/BEIJING (Reuters) - China... told Reuters.
Chinas medical products regulator -…
Pfizer, China in discussions to license to generic version of COVID drug Paxlovid
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September
BioNTech, which worked with Pfizer to build an mRNA Covid vaccine, has partnered with the U.K. to turn the technology…
Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE
Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE...…
UPDATE 1-Pfizer to scale down early-stage rare disease research
...(Changes source, adds Pfizer statement)
Jan 5 (Reuters) - U.S. pharma... disease and oncology," a
spokesperson said in a statement to Reuters,…
BRIEF-Pfizer Says It Will Be Shifting To Invest In Rare And Benign Hematology And Platforms Such As Gene Editing Through External Innovation On Rare Conditions
...Jan 5 (Reuters) -
* PFIZER SAYS WILL BE SHIFTING TO INVEST IN RARE......…
Pfizer could sell some assets, convert others into new companies amid broader refocus
Drug maker Pfizer Inc. could part with or otherwise distance itself from some of its research programs....…
Pfizer to Pull Back on Research Into Rare Disease, Gene Therapy
As part of the shift, the company may sell assets like its gene therapy facility in Durham and a cancer-focused…
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…
Thursday’s Top Analyst Upgrades and Downgrades: Baidu, BNY Mellon, Corning, Merck, Meta Platforms, Microsoft, Pfizer, Rivian, Target and More
Thursdays top analyst upgrades and downgrades included Baidu, Bank of New York Mellon, Charles Schwab, Corning, Livent, Merck, Meta Platforms,…
Wegen Impf-Flaute - Dermapharm am unteren Ende der Erwartungen
München (Reuters) - Die stark abflauende Nachfrage nach Corona-Impfstoff setzt dem Arzneimittel-Hersteller Dermapharm zu.
Das Unternehmen aus Grünwald bei München…
Pfizer: Downgrade
Charlotte (www.aktiencheck.de) - Rating-Update:
Geoff Meacham, Analyst von BofA Securities, stuft die Aktie des Pharma-Giganten Pfizer Inc. (ISIN: US7170811035, WKN: 852009,…
As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer
Bank of America analysts downgraded the stock to neutral from buy...…
Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another
The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst…
Why Pfizer (PFE) Could Beat Earnings Estimates Again
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Serie: Branchenausblick: Die Pharmaindustrie steht nach dem Corona-Boom vor einer Wachstumsdelle
Der Schub durch Covid-Impfstoffe und Medikamente flaut ab, gleichzeitig läuft für einige Produkte der Patentschutz ab. Novo Nordisk löst Pfizer…
Pfizer (PFE) Gains As Market Dips: What You Should Know
In the latest trading session, Pfizer (PFE) closed at $51.26, marking a +0.04% move from the previous day....…
BioNTech: Bundesregierung bemüht sich, überschüssige Impfstofflieferungen zu reduzieren - Aktienanalyse
Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…
Tuesday’s Top Analyst Upgrades and Downgrades: Ally Financial, Apple, Block, DR Horton, EOG, Ford, Micron, PayPal, Pfizer and More
Tuesdays top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu,…
BioNTech: Abnahmeverpflichtung für 375 Millionen Dosen Impfstoff
Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von BioNTech und dem dazugehörigen amerikanischen Pharma-Partner Pfizer abzunehmen. Das…
Abnahmeverpflichtung für 375 Millionen Dosen Biontech-Impfstoff
BERLIN (dpa-AFX) - Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von Biontech (BioNTech (ADRs))/Pfizer (Pfizer) abzunehmen. Das…
Chinesen können sich in Hongkong mit BionTech boostern lassen
Hongkong (Reuters) - Chinesen können sich offenbar bald in Hongkong mit dem Impfstoff von BioNTech gegen Covid-19 boostern lassen.
Der…
EU-Kommission will wegen Impfstoff-Überschüssen mit Herstellern und Mitgliedstaaten beraten
Berlin (Reuters) - In der Europäischen Union wächst die Sorge vor einem milliardenteuren Überschuss an nicht benötigten Corona-Impfstoffen.
Die Kommission…